GCIA
INSM icon

Gabelli & Co Investment Advisers’s Insmed INSM Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267K Buy
+2,500
New +$303K 0.04% 228

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Gabelli & Co Investment Advisers's INSM Position: Q2 2026 in Review

Gabelli & Co Investment Advisers opened a new position in Insmed (INSM) in Q2 2026: 2,500 shares worth $267K. The stake represents 0.04% of the portfolio and ranks #228 among its holdings.

664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Gabelli & Co Investment Advisers held 2,500 shares of Insmed worth $267K as of Q2 2026.
  • Insmed was a new Gabelli & Co Investment Advisers position in Q2 2026.
  • Insmed made up 0.04% of Gabelli & Co Investment Advisers's portfolio in Q2 2026, its #228 holding.
  • 664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.